vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.
You can purchase shares of vTv Therapeutics (NASDAQ:VTVT) through any online brokerage.
Other companies in vTv Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), OncoCyte (NASDAQ:OCX) and Gain Therapeutics (NASDAQ:GANX).
vTv Therapeutics has a consensus price target of $4.33.
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $16 last updated October 24, 2024 at 7:49 AM EDT.
There are no upcoming dividends for vTv Therapeutics.
vTv Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for vTv Therapeutics.
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.